[1] |
LIU Xiao-li, LEI Li-mei, GUO Zhou-li, HUANG Yin, XU Jing, ZHAO Xia, WANG Yan, FU Li.
Study on the relationship of stigma and social support of tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 1002-1008.
|
[2] |
ZHOU Lin, LIU Er-yong, MENG Qing-lin, CHEN Ming-ting, ZHOU Xin-hua, GAO Wei-wei, LIN Ming-gui, XIE Ru-ming.
Evaluation of the quality of pulmonary tuberculosis diagnosis after the implementation of the newly revised WS 288-2017 Diagnosis for pulmonary tuberculosis standards
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 910-915.
|
[3] |
MENG Qing-lin, LI Jin-lan, LIN Ding-wen, MA Yong-cheng, HOU Shuang-yi, LIU Nian-qiang, ZHOU Lin.
Analysis of the awareness about knowledge on the updated TB diagnosis standard among the practitioners in TB control institutions
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 921-925.
|
[4] |
SU Qian, XIA Yong, LU Jia, WANG Dan-xia, HE Jin-ge.
Analysis on the epidemiological characteristics of pulmonary tuberculosis among children aged 0-14 in Sichuan Province from 2009 to 2018
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 942-947.
|
[5] |
LIANG Rui-yun, FANG Wei-jun, REN Hui-li, LI Hui-ru, ZHANG Hui.
Study on CT manifestations of non-tuberculous mycobacterium pulmonary disease patients with and without diabetes mellitus
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 962-967.
|
[6] |
MA Ting-long, HAN Yi, CHENG Xu, LIU Zhi-dong.
Clinical observation on treatment effectiveness of transdermal ultrasound-mediated drug delivery combined with oral anti-tuberculosis drug in patients with chest wall tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 968-972.
|
[7] |
NAN Hai, ZHANG Yun, YANG Xin-ting, DUAN Hong-fei.
Meta-analysis on the diagnostic value of GeneXpert MTB/RIF for bone and joint tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 973-980.
|
[8] |
ZHANG Li-juan, TAO Xiao, XIA Li-li, WEI Fen-fen, ZHENG Qi.
Value of clinical pathway table of enhanced recovery cluster nursing in patients with spinal tuberculosis during perioperative period
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 981-986.
|
[9] |
CHEN Yu-mei, LUO Xing-xiong, CHEN Cheng-jiang, SU Ping, WANG Chun-lei..
Analysis of the service capability in city/county tuberculosis designated hospital in Hainan
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 992-993.
|
[10] |
SUN Hai-yan, LI Shuo, WANG Zhong-dong, REN Zhi-sheng, SONG Song, XUE Bai, ZHANG Hua-qiang, DAI Xiao-qi.
Characteristics of the tuberculosis epidemic in schools in Qingdao in 2010—2019
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 994-997.
|
[11] |
LI Ai-fang, CUI Xiao-li, KANG Lei, LEI Jing, DANG Li-yun, YANG Han.
Value of fluorescence PCR probe melting curve method in detecting resistance of Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 998-1001.
|
[12] |
Chinese Antituberculosis Association, Schools and Children Branch of the Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis .
Expert consensus of clinical application of the recombinant Mycobacterium tuberculosis fusion protein (EC)
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 761-768.
|
[13] |
YANG Lei, WEI Fen, ZHANG Kai, QIU Jing-jing, WANG Ying-ying, DU Wei-xin, LU Jin-biao, TAO Li-feng, PU Jiang.
Stability and efficacy study of recombinant Mycobacterium tuberculosis fusion protein (EC)
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 799-806.
|
[14] |
ZHANG Kai, TAO Li-feng, WEI Fen, DU Wei-xin, QIU Jing-jing, CHEN Wei, CHEN Bao-wen, ZHU Yin-meng, CHENG Xing, SU Cheng, ZHONG Zai-xin, LU Jin-biao, PU Jiang.
Immune characteristics and preclinical animal safety studies of recombinant Mycobacterium tuberculosis fusion protein(EC)
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 807-813.
|
[15] |
ZHANG Kai, SHEN Xiao-bing, TAO Li-feng, WEI Fen, CHEN Bao-wen, QIU Jing-jing, CHEN Wei, LU Jin-biao, ZHU Yin-meng, CHENG Xing, ZHONG Zai-xin, ZHAO Ai-Hua, PU Jiang.
Establishment of quality standards for recombinant Mycobacterium tuberculosis fusion protein
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 814-820.
|